On Wednesday, Shares of Michael Kors Holdings Ltd (NYSE:KORS), subtract 0.28% and closed at $50.18 in the last trading session. The last trading range of the stock ranges between $48.94 and $50.82. Michael Kors Holdings Limited (KORS) (the “Company”), a global luxury lifestyle brand, recently declared that Robin Freestone has been designated to the Company’s Board of Directors, effective right away. The appointment of Mr. Freestone brings the Company’s Board membership to nine, and the Company will have seven independent directors.
Mr. Freestone is an esteemed FTSE 100 executive with noteworthyexperience across a broad array of international businesses. From 2006 through August 2015, Mr. Freestone was Chief Financial Officer of Pearson Plc, having formerly served as Deputy Chief Financial Officer since 2004. Before that, he held a number of senior financial positions at Amersham plc from 2000 to 2004, Henkel Chemicals UK Ltd from 1995 to 2000 and ICI/Zeneca Agrochemicals Ltd (now Syngenta) from 1985 to 1995. He began his financial and accounting career at Touche Ross (now Deloitte). Presently, Mr. Freestone also serves as a non-executive director of Smith and Nephew plc and moneysupermarket.com.
Qiagen NV (NASDAQ:QGEN), jumped 3.73% and closed at $28.34 in the last trading session. The last trading range of the stock ranges between $27.25 and $28.50. The company’s Market capitalization is $6.75 Billion with the total Outstanding Shares of 234.25 million. QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) recently declared a partnership with lab informatics company Genohm to empower GeneReader NGS System users with seamless data administration by integrating the NGS workflow with their laboratory information administration systems (LIMS). QIAGEN’s Sample to Insight next-generation sequencing (NGS) solution is supported by GeneRead Link, a middleware co-developed by the two companies to ensure complete chain of custody from sample processing to final reports – with full connectivity into the leading LIMS systems. In addition, GeneReader NGS System customers who do not already have a LIMS solution can benefit from easy connectivity into Genohm’s proprietary SLims solution to assist manage all data across the laboratory. Both companies will continue to enhance GeneRead Link and adapt the middleware solution as required to support future GeneReader workflows.
National Retail Properties, Inc. (NYSE:NNN), lost -4.82% and closed at $42.25 in the last trading session. The last trading range of the stock ranges between $42.15 and $45.31. During the 52-week trading session the minimum price at which share price traded, registered at $35.98 and reached to max level of $53.60. National Retail Properties, Inc. (NNN), a real estate investment trust, recently declared its operating results for the quarter and nine months ended September 30, 2016. Highlights include:
Third Quarter 2016 Highlights:
Core FFO per share raised 1.7% over prior year results
AFFO per share raised 3.4% over prior year results
Portfolio occupancy was 99.0% at September 30, 2016 as contrast to 99.1% at June 30, 2016 and March 31, 2016
Invested $127.8 million in property investments, counting the acquisition of 38 properties with an aggregate 350,000 square feet of gross leasable area at an initial cash yield of 7.1%
Sold seven properties for $10.6 million producing $4.5 million of gains on sales
Raised $56.8 million net proceeds from the issuance of 1,117,897 common shares
In October 2016, the company raised $334.3 million in net proceeds from the issuance of 13,800,000 depositary shares representing interests in its 5.20% Series F preferred stock.